News | July 26, 2022
Cadila Pharma bags ‘Rising Digital Star’ award at DigipharmaX
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The tenure of contract will be upto 10 years from date of signing the contract/installation.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
WuXi STA opens a new large scale continuous manufacturing plant
Subscribe To Our Newsletter & Stay Updated
